Taysha Gene Therapies President, Head of R&D Sukumar Nagendran disposes of 200,000 common shares for $1.25 million - TSHA News | RalliesTaysha Gene Therapies President, Head of R&D Sukumar Nagendran disposes of 200,000 common shares for $1.25 million
T
TSHA• Insider share sale
- Taysha Gene Therapies President and Head of R&D Sukumar Nagendran sold 200,000 common shares on July 10, 2026.
- The sale was priced at $6.24 per share on a weighted-average basis.
- After the transaction, Nagendran held 936,410 shares directly.
•
